New Tokyo location in transportation hub spot to service expanding Credo on Demand rental program
British manufacturer Peli BioThermal has announced the opening of its new service centre in Japan.
The new facility, which is the latest location to be added to the company’s growing network in Asia, is ideally situated near Tokyo’s international Narita Airport.
The latest location will also serve as an additional network station for the company’s rapidly expanding Crēdo on Demand rental program, which offers a high-performance, flexible rental option for temperature controlled pallet shippers, with worldwide reach.
Benson Teo, Peli BioThermal’s Senior Director of sales, Asia, said: “Japan continues to be one of the largest pharmaceutical markets in the world, which makes the launch of our latest service center a strong strategic solution. It is ideally placed within an area offering numerous transportation options, helping us to better meet the requirements of our global customers."
We are also delighted to announce our products will be shipped via airlines operating in the region including ANA and the JAL Group, which has the most comprehensive handling network in Japan providing ground handling services at numerous airports in Japan
Strategically located within Tokyo, Peli BioThermal’s latest facility is in close proximity to Narita Airport and will be able to support Japan’s thriving biotech sector. Tokyo is also home to a number of leading healthcare companies including Takeda, Astellas Pharma, Pfizer Japan, GlaxoSmithKline, Novartis Japan and Eisai.
To mark the official opening of the new facility a grand opening event was held on Wednesday, 7 September.
Teo added: “We are also delighted to announce our products will be shipped via airlines operating in the region including ANA and the JAL Group, which has the most comprehensive handling network in Japan providing ground handling services at numerous airports in Japan.”
This latest location joins the expanding network of Peli BioThermal facilities servicing key hubs for pharmaceutical manufacturing and transfer activities and is available to customers on a global scale.